Detection of Numerical Chromosome Aberrations in Bladder Cancer by in Situ Hybridization

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 1989 Dec 1

PMID 2688431

Citations 15

Authors

A H Hopman

P J Poddighe

A W Smeets

O Moesker

J L Beck

G P Vooijs

F C Ramaekers

Affiliations

Soon will be listed here.

Abstract

The nuclear DNA content of 53 transitional cell carcinomas (TCCs) of the urinary bladder, as determined by flow cytometry (FCM), was compared with chromosome ploidy as detected by nonradioactive in situ hybridization (ISH). For this purpose, probes for repetitive DNA targets in the (peri) centromeric region of chromosomes 1 and 18 were used. Hybridization results with both probes of 35 TCCs, which had a DNA index of approximately 1.0 as concluded from FCM, showed evident chromosome 1 aberrations in approximately 25% of the tumors, and in a few cases an aberration for chromosome 18 was detected. Comparison of the ISH spot numbers for both chromosomes showed in most cases a higher number for chromosome 1 than for chromosome 18. ISH on 18 cases of TCCs, which showed a single peak in FCM with a DNA-index of 1.2 to 3.2, exhibited a profound heterogeneity. In these TCCs the ratio between chromosomes 1 and 18 varied over a wide range, resulting in cases showing more hybridization signals for chromosome 1 than for chromosome 18 or the opposite. Furthermore, using ISH minor cell populations showing polyploidization and giant cells containing numerous ISH signals could occasionally be detected. Results showed that interphase cytogenetics by ISH enable a fast screening of numerical chromosome aberrations and detection of different cell populations within one tumor, which was apparently homogeneous according to FCM.

Citing Articles

Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

Holst F World J Clin Oncol. 2016; 7(2):160-73.

PMID: 27081639 PMC: 4826962. DOI: 10.5306/wjco.v7.i2.160.

Diagnosis of Sex Chromosome Disorders and Prenatal Diagnosis of Down Syndrome using Interphase Fluorescent In-Situ Hyperidization Technique.

Settin A, Abu-Saif I, El-Baz R, Dowaidar M, Kasim R, Shabana S Int J Health Sci (Qassim). 2011; 1(2):203-9.

PMID: 21475429 PMC: 3068641.

Biomarkers for detection and surveillance of bladder cancer.

Budman L, Kassouf W, Steinberg J Can Urol Assoc J. 2008; 2(3):212-21.

PMID: 18682775 PMC: 2494897. DOI: 10.5489/cuaj.600.

Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?.

Krause F, Rauch A, Schrott K, Engehausen D World J Urol. 2006; 24(4):418-22.

PMID: 16688457 DOI: 10.1007/s00345-006-0086-y.

Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications.

Davison J, Morgan T, Hsi B, Xiao S, Fletcher J Am J Pathol. 1998; 153(5):1401-9.

PMID: 9811331 PMC: 1853394. DOI: 10.1016/S0002-9440(10)65727-6.

References

Merkel D, Dressler L, McGuire W . Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol. 1987; 5(10):1690-703. DOI: 10.1200/JCO.1987.5.10.1690. View

Hopman A, Wiegant J, VAN DUIJN P . Mercurated nucleic acid probes, a new principle for non-radioactive in situ hybridization. Exp Cell Res. 1987; 169(2):357-68. DOI: 10.1016/0014-4827(87)90196-0. View

Babu V, Lutz M, Miles B, Farah R, WEISS L, Van Dyke D . Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. Cancer Res. 1987; 47(24 Pt 1):6800-5. View

Vanni R, Scarpa R, Nieddu M, Usai E . Cytogenetic investigation on 30 bladder carcinomas. Cancer Genet Cytogenet. 1988; 30(1):35-42. DOI: 10.1016/0165-4608(88)90090-8. View

Cremer T, Tesin D, Hopman A, Manuelidis L . Rapid interphase and metaphase assessment of specific chromosomal changes in neuroectodermal tumor cells by in situ hybridization with chemically modified DNA probes. Exp Cell Res. 1988; 176(2):199-220. DOI: 10.1016/0014-4827(88)90325-4. View

Hopman A, Ramaekers F, Raap A, Beck J, Devilee P, VAN DER PLOEG M . In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 1988; 89(4):307-16. DOI: 10.1007/BF00500631. View

Devilee P, Thierry R, Kievits T, Kolluri R, Hopman A, Willard H . Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res. 1988; 48(20):5825-30. View

Cremer T, Lichter P, Borden J, Ward D, Manuelidis L . Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum Genet. 1988; 80(3):235-46. DOI: 10.1007/BF01790091. View

Teyssier J . The chromosomal analysis of human solid tumors. A triple challenge. Cancer Genet Cytogenet. 1989; 37(1):103-25. DOI: 10.1016/0165-4608(89)90080-0. View

10.

Minowada J, Onuma T, Moore G . Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst. 1972; 49(3):891-5. View

11.

Bubenik J, BARESOVA M, Viklicky V, Jakoubkova J, Sainerova H, Donner J . Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer. 1973; 11(3):765-73. DOI: 10.1002/ijc.2910110327. View

12.

Fossa S, Kaalhus O . Nuclear size and chromatin concentration in transitional cell carcinoma of the human urinary bladder. Beitr Pathol. 1976; 157(2):109-25. DOI: 10.1016/s0005-8165(76)80098-4. View

13.

Cox R, IRVING C . Inhibition of DNA methylation by S-adenosylethionine with the production of methyl-deficient DNA in regenerating rat liver. Cancer Res. 1977; 37(1):222-5. View

14.

Cooke H, Hindley J . Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res. 1979; 6(10):3177-97. PMC: 327928. DOI: 10.1093/nar/6.10.3177. View

15.

Summers J, FALOR W, WARD R . A 10-year analysis of chromosomes in non-invasive papillary carcinoma of the bladder. J Urol. 1981; 125(2):177-8. DOI: 10.1016/s0022-5347(17)54954-x. View

16.

Langer P, Waldrop A, Ward D . Enzymatic synthesis of biotin-labeled polynucleotides: novel nucleic acid affinity probes. Proc Natl Acad Sci U S A. 1981; 78(11):6633-7. PMC: 349103. DOI: 10.1073/pnas.78.11.6633. View

17.

Brigati D, Myerson D, Leary J, Spalholz B, Travis S, Fong C . Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labeled hybridization probes. Virology. 1983; 126(1):32-50. DOI: 10.1016/0042-6822(83)90460-9. View

18.

Barlogie B, Raber M, Schumann J, Johnson T, Drewinko B, Swartzendruber D . Flow cytometry in clinical cancer research. Cancer Res. 1983; 43(9):3982-97. View

19.

Wijkstrom H, Tribukait B . Chromosomal and DNA patterns in transitional cell bladder carcinoma. A comparative cytogenetic and flow-cytofluorometric DNA study. Cancer. 1984; 53(8):1718-23. DOI: 10.1002/1097-0142(19840415)53:8<1718::aid-cncr2820530817>3.0.co;2-e. View

20.

Atkin N, Baker M . Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11. Cancer Genet Cytogenet. 1985; 15(3-4):253-68. DOI: 10.1016/0165-4608(85)90169-4. View